It has been shown that lowering serum uric acid with either a xanthine oxidase inhibitor (allopurinol or febuxostat) or with the uricosuric, benzbromarone, could ameliorate the features of the metabolic syndrome in the fructose-fed rat. Here, XDH is linked to metabolic syndrome.